Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 14 de 14
Filtrar
1.
Aging Clin Exp Res ; 29(Suppl 1): 109-113, 2017 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-27837459

RESUMO

BACKGROUND: Endoscopic mucosal resection (EMR) of early superficial colorectal carcinomas is nowadays accepted as the gold standard treatment for this type of neoplasia. AIM: This study aims to evaluate the efficacy and safety of mucosectomy in elderly patients considering the predictive value of submucosal infiltration. METHODS: A retrospective study of all patients referred for EMR of sessile colorectal polyps classified IIa by the Paris classification between April 2013 and April 2015. A total of 50 patients (30 males (60 %); age range = 44-86; mean age = 67.7) were enrolled. Patients were divided in two groups considering 65 years as cutoff to individuate the elderly patients. RESULTS: EMR was performed in 53 lesions: 39 were performed en bloc and 14 by piecemeal technique. 30 % of lesions were in the rectum; 11 % in the sigmoid colon; 15 % in the descending colon; 6 % in the transverse colon; 24 % in the ascendant colon; and 14 % in the cecum. The mean size of the resected specimens was 20 mm (range 8-80 mm). The rate of complete resection was 79.2 %, incomplete 13.2 %, not estimable 7 %. Ten patients underwent surgery because of an incomplete resection and/or histological evaluation. CONCLUSIONS: Colon EMR is safe and effective in elderly patients. Endoscopy is still helped in the correct indication for surgery in high-risk surgical patients.


Assuntos
Colonoscopia , Neoplasias Colorretais , Ressecção Endoscópica de Mucosa , Idoso , Idoso de 80 Anos ou mais , Colonoscopia/efeitos adversos , Colonoscopia/métodos , Neoplasias Colorretais/patologia , Neoplasias Colorretais/cirurgia , Ressecção Endoscópica de Mucosa/efeitos adversos , Ressecção Endoscópica de Mucosa/métodos , Feminino , Humanos , Mucosa Intestinal/patologia , Mucosa Intestinal/cirurgia , Itália , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Resultado do Tratamento
2.
J Clin Gastroenterol ; 46(4): 302-7, 2012 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-21934529

RESUMO

BACKGROUND: Celiac disease (CD)-related lesions were described in duodenal bulb of celiac patients. GOAL: Our aim was to evaluate the morphology of bulb mucosa in adult celiac patients and in controls to evaluate its usefulness for CD diagnosis. STUDY: We studied 43 celiac patients (10 male, median age: 35.2 y) at diagnosis and 43 gastroenterological controls (10 male, median age: 37.8 y), submitted to upper endoscopy for gastroenterological complaints. Histologic lesions were assayed by an experienced pathologist according to the Marsh modified classification. Antiendomysium antibodies and antitransglutaminase antibodies-tTGAb (ELISA and/or RIA) have been tested. In selected patients, DNA was typed for DRB1, DQA1, and DQB1 genes by sequence-specific primer polymerase chain reaction. RESULTS: In all celiac patients lesions were present in the bulb mucosa. One female with thyroiditis, who had a CD daughter, showed lesions only in the duodenal bulb. Patchy villous atrophy was found in another patient. All celiacs were antiendomysium and/or tTGAb positive. DQ2 heterodimer was present in 5 CD patients. The gastroenterological controls showed normal mucosa in the duodenum. CONCLUSIONS: This study demonstrates that CD-related histologic lesions are present in duodenal bulb of adult patients. Moreover, the normal aspect of this mucosa in gastroenterological controls implies the high negative predictive value of this finding. Therefore, we suggest taking at least 1 biopsy on the bulb area and 1 from the distal duodenum for CD diagnosis, in all the patients submitted to upper endoscopy, to avoid missed or delayed diagnosis.


Assuntos
Doença Celíaca/diagnóstico , Duodeno/patologia , Cadeias alfa de HLA-DQ/genética , Cadeias beta de HLA-DQ/genética , Adolescente , Adulto , Biópsia , Doença Celíaca/patologia , Ensaio de Imunoadsorção Enzimática , Feminino , Cadeias HLA-DRB1/genética , Humanos , Mucosa Intestinal/patologia , Masculino , Pessoa de Meia-Idade , Reação em Cadeia da Polimerase , Radioimunoensaio , Adulto Jovem
3.
Rev Esp Enferm Dig ; 104(11): 607-10, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-23368654

RESUMO

Gastrointestinal anisakiasis is a parasitic infection occurring in people that consume raw or inadequately cooked fish or squid. It is frequently characterized by severe epigastric pain, nausea and vomiting caused by the penetration of the larvae into the gastric wall. Acute gastric anisakiasis with severe chest discomfort is rarely reported in Italy. On the other hand, gastro-allergic anisakiasis with rash, urticaria and isolated angioedema or anaphylaxis is a clinical entity that has been described only recently. Also, if patients usually develop symptoms within 12 hours after raw seafood ingestion, not always endoscopic exploration can promptly identify the Anisakis larvae. Moreover, some authors consider the prevailing allergic reaction as a natural and effective defense against the parasitic attack. We report two cases of peculiar manifestations of anisakiasis in both acute and chronic forms (severe chest discomfort and anaphylactoid reaction).


Assuntos
Anisaquíase/parasitologia , Anisaquíase/terapia , Interações Hospedeiro-Parasita , Adulto , Albendazol/uso terapêutico , Animais , Anisaquíase/patologia , Anisakis , Anti-Helmínticos/uso terapêutico , Anticorpos Anti-Helmínticos/análise , Doença Crônica , Edema/etiologia , Feminino , Contaminação de Alimentos , Humanos , Imunoglobulina G/análise , Masculino , Pessoa de Meia-Idade , Alimentos Marinhos , Estômago/parasitologia , Estômago/patologia
4.
Ann Ital Chir ; 82(2): 159-62, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21682109

RESUMO

Condyloma acuminatum (CA) is a sexually transmitted disease caused by human papilloma virus (HPV). Infection with HPV is a major risk factor for development of anal squamous cell carcinoma. In clinical practice, it is frequently limited to the perianal skin or anal canal and it is rarely described a rectal mucosal extension. Several therapeutic options are developed for CA, including chemical or physical destruction, immunological therapy, or a surgical excision. However, these treatments still have some degree of limitations and important side effects compromising patient compliance and reducing treatment efficacy. CO2-laser emits a continuous beam, absorbed by biologic tissues, that vaporizing intracellular water, destroys target lesions. Argon plasma coagulator (APC) is a non-contact method of endoscopically delivered high-frequency thermal coagulation allowing well-controlled superficial tissue destruction. We present a case of a young female affected by anorectal condiloma extended to rectum, that was successfully treated with combined ginecological (carbon dioxide laser) and endoscopic approach (argon plasma coagulator), with no side effects during the follow up and complete remission after two applications.


Assuntos
Doenças do Ânus/cirurgia , Coagulação com Plasma de Argônio , Condiloma Acuminado/cirurgia , Lasers de Gás , Doenças Retais/cirurgia , Adulto , Feminino , Humanos , Proctoscopia , Resultado do Tratamento
5.
Ann Ital Chir ; 82(4): 297-300, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21834480

RESUMO

Gastric hyperplastic polyps are often asymptomatic and are found incidentally at upper endoscopy performed for unrelated reasons. Although they are considered a benign lesion, all symptomatic polyps should be removed for a more reliable histological diagnosis, resolution of symptoms and to prevent potential malignant transformation. In fact, there are no significant difference between pure gastric hyperplastic polyps and gastric hyperplastic polyps with neoplastic transformation in the number, location, or gross appearance of polyps. If symptomatic, patients usually complain of dyspepsia, heartburn, abdominal pain or upper gastrointestinal bleeding leading to anaemia. Complete or incomplete gastric outlet obstruction with intermittent symptoms, may rarely be caused by gastric hyperplastic polyps. We described the management of a rare case of intermittent gastric outlet obstruction caused by a large hyperplastic antral polyp prolapsing through the pylorus. Using hydroxypropylmethylcellulose, a new lifting agent, firstly from pyloric side, we obtained a reliable long-lasting submucosal cushion under the lesion which allowed a stable repositioning of the polyp in the gastric lumen without making additional infiltration during the endoscopic mucosal resection. Innovative lifting agents could significantly reduce the procedure time, but additional studies should be performed on this area to confirm preliminary results. Endoscopic mucosal resection not only provides tissue to determine the exact histopathologic type of the polyp, but also achieves symptomatic treatment.


Assuntos
Obstrução da Saída Gástrica/etiologia , Obstrução da Saída Gástrica/cirurgia , Gastroscopia , Pólipos/complicações , Antro Pilórico , Idoso de 80 Anos ou mais , Humanos , Hiperplasia , Masculino , Pólipos/patologia , Gastropatias/complicações , Gastropatias/patologia
6.
J Dig Dis ; 19(1): 40-47, 2018 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-29266839

RESUMO

OBJECTIVE: To evaluate the impact of a new same-day, low-dose 1-L polyethylene glycol-based (1-L PEG) bowel preparation on the diagnostic rating of selected hospitalized patients and its tolerability, with risk factors for inadequate bowel preparation. METHODS: A single-center prospective pilot study was conducted with hospitalized patients scheduled for colonoscopy, presenting risk factors for poor bowel preparation, such as bleeding or subocclusive symptoms. The included patients were randomly divided in two groups, which received either a same-day 1-L PEG (group A) or a split-dose 4-L PEG (group B), and performed a colonoscopy within 4 h of the last dose. RESULTS: In all, 44 inpatients [27 males; mean age 63.5 years (range 20-94 years)] were enrolled. Optimal bowel cleansing was reached in 64% and 55% (P = 0.64) of patients in groups A and B, respectively. The adenoma detection rate was 14% (group A) and 18% (group B) (P = 0.34). A valid diagnosis was reached in 38 (86%) of 44 patients (21 in group A and 17 in group B) after a mean hospitalization of 3 days for group A and 6 days for group B (P = 0.04). CONCLUSIONS: Our data support the conclusion that the schedule protocol proposed in this study enables a clear diagnosis in most of the inpatients at high risk of poor bowel preparation and no statistical differences were found between the two groups in terms of successful bowel cleansing achieved. Therefore, the same-day, low-dose 1-L PEG bowel preparation could be introduced for selected inpatients.


Assuntos
Catárticos/administração & dosagem , Doenças do Colo/diagnóstico , Colonoscopia/métodos , Obstrução Intestinal/diagnóstico , Polietilenoglicóis/administração & dosagem , Adulto , Idoso , Idoso de 80 Anos ou mais , Catárticos/efeitos adversos , Neoplasias do Colo/complicações , Neoplasias do Colo/diagnóstico , Esquema de Medicação , Feminino , Hospitalização , Humanos , Obstrução Intestinal/etiologia , Masculino , Pessoa de Meia-Idade , Projetos Piloto , Polietilenoglicóis/efeitos adversos , Estudos Prospectivos , Fatores de Risco , Adulto Jovem
7.
United European Gastroenterol J ; 4(6): 778-783, 2016 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-28408995

RESUMO

BACKGROUND: The safety and diagnostic accuracy of colonoscopy depend on the quality of colon cleansing. The adenoma detection rate is usually used as a quality measurement score. OBJECTIVE: We aimed to introduce and evaluate three new parameters to determine polyps and adenomas segmental localization and their distribution in association with different bowel preparation levels during colonoscopy. We introduce the multiple adenoma detection rate (the percentage of patients with >2 adenomas diagnosed during colonoscopy), the zonal adenoma detection rate (the percentage of patients with >2 adenomas diagnosed during colonoscopy in different colon areas (rectum, sigmoid, descending, transverse, ascending and cecum colon)), and multi-zone adenoma detection rate (the percentage of patients with >2 adenomas diagnosed during colonoscopy in different colon areas with at least a segment between them with or without lesions (i.e. rectum and descending colon with or without lesions in the sigmoid)). METHODS: We prospectively enrolled outpatients who underwent colonoscopy from January 2013 to October 2014. The bowel preparation quality, according to the Aronchick modified scale, number and location of lesions, Paris classification and histology, were recorded. The multiple adenoma/polyp detection rate, zonal adenoma/polyp detection rate, and multi-zone adenoma/polyp detection rate were determined. RESULTS: In total, 519 consecutive patients (266/253 M/F; mean age 55.3 ± 12.8 years) were enrolled. The adenoma and polyp detection rates were 21% and 35%, respectively. Multiple adenomas were detected in 28 patients. Adenoma and polyp detection rate and new parameters were statistically significantly higher in the optimal as compared with the adequate bowel preparation. CONCLUSIONS: An optimal level of bowel preparation was strongly associated not only with a higher adenoma detection rate, but also with a higher chance of detecting multiple clinically relevant lesions in adjacent or discrete segments of the colon.

8.
Saudi J Gastroenterol ; 21(2): 111-5, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25843198

RESUMO

BACKGROUND/AIMS: Endoscopy is an essential and very commonly used procedure for the evaluation of a multitude of gastrointestinal symptoms. Although it is increasingly required, patients often wait on arrival at the endoscopy unit until they are called for the procedure. It is not clear whether or not this waiting time may have an impact on patient's tolerance during upper endoscopy. Our study attempts to address this. PATIENTS AND METHODS: We studied consecutive outpatients who underwent endoscopy from September to December, 2013. Gender, age, body mass index (BMI), previous endoscopic experiences, antidepressant therapy, and the time interval between arrival at the endoscopy unit and the onset of examination was recorded. Anxiety before the procedure, pain, and discomfort were rated by a numeric rating scale (0 = no pain/discomfort encountered to 10 = extremely painful/uncomfortable). RESULTS: One hundred and five consecutive outpatients (male = 52; mean age = 45.3 years; age range = 20-86 years) were included in the study. The mean BMI was 25 ± 4.8; mean waiting time from registration to the procedure was  172 min (time range = 30 - 375 mins). Mean patients' pre-examination anxiety level was 3 ± 3.84, mean discomfort score was 4.3 ± 3.09 and mean pain score was 3.4 ± 3.03. The level of pain and discomfort was significantly higher in patients with higher levels of pre-procedure anxiety. No differences were found in terms of anxiety, pain and discomfort among patients divided according to waiting time. CONCLUSIONS: According to our data, waiting time does not have a significant impact on the perception of pain and discomfort related to the endoscopic procedure. On the other hand, high pre-procedural levels of anxiety were associated with a low tolerance. Further multicenter randomized trials are needed to clarify the impact of waiting time.


Assuntos
Ansiedade/psicologia , Endoscopia Gastrointestinal/psicologia , Gastroenteropatias/diagnóstico , Cooperação do Paciente/psicologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Ansiedade/etiologia , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Adulto Jovem
9.
ISRN Gastroenterol ; 2014: 681978, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24729880

RESUMO

Purpose. Bowel preparation for surveillance endoscopy following surgery can be impaired by suboptimal bowel function. Our study compares two groups of patients in order to evaluate the influence of colorectal resection on bowel preparation. Methods. From April 2010 to December 2011, 351 patients were enrolled in our retrospective study and divided into two homogeneous arms: resection group (RG) and control group. Surgical methods were classified as left hemicolectomy, right hemicolectomy, anterior rectal resection, and double colonic resection. Bowel cleansing was evaluated by nine skilled endoscopists using the Aronchick scale. Results. Among the 161 patients of the RG, surgery was as follows: 60 left hemicolectomies (37%), 62 right hemicolectomies (38%), and 33 anterior rectal resections (20%). Unsatisfactory bowel preparation was significantly higher in resected population (44% versus 12%; P value = 0.000). No significant difference (38% versus 31%, P value = ns) was detected in the intermediate score, which represents a fair quality of bowel preparation. Conclusions. Our study highlights how patients with previous colonic resection are at high risk for a worse bowel preparation. Currently, the intestinal cleansing carried out by 4 L PEG based preparation does not seem to be sufficient to achieve the quality parameters required for the post-resection endoscopic monitoring.

10.
J Gastrointest Surg ; 15(8): 1480-1, 2011 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-21484484

RESUMO

Endoscopic mucosal resection is a potential alternative to surgery when submucosal invasion and lymph node involvement are excluded. We describe an en bloc resection of a large, focal, high-grade tubulovillous nonampullary adenoma of duodenal wall using hydroxypropyl methylcellulose as a lifting agent.


Assuntos
Adenoma/cirurgia , Neoplasias Duodenais/cirurgia , Duodenoscopia/métodos , Metilcelulose/análogos & derivados , Adenoma/patologia , Idoso , Neoplasias Duodenais/patologia , Feminino , Humanos , Derivados da Hipromelose , Injeções , Mucosa Intestinal/cirurgia , Metilcelulose/administração & dosagem
11.
World J Gastroenterol ; 17(42): 4689-95, 2011 Nov 14.
Artigo em Inglês | MEDLINE | ID: mdl-22180711

RESUMO

AIM: To investigate the effectiveness of low-volume plus ascorbic acid [polyethylene glycol plus ascorbic acid (PEG + Asc)] and high-volume plus simethicone [polyethylene glycol plus simethicone (PEG + Sim)] bowel preparations. METHODS: A total of one hundred and forty-four outpatients (76 males), aged from 20 to 84 years (median age 59.5 years), who attended our Department, were divided into two groups, age and sex matched, and underwent colonoscopy. Two questionnaires, one for patients reporting acceptability and the other for endoscopists evaluating bowel cleansing effectiveness according to validated scales, were completed. Indications, timing of examination and endoscopical findings were recorded. Biopsy forceps were used as a measuring tool in order to determine polyp endoscopic size estimation. Difficulty in completing the preparation was rated in a 5-point Likert scale (1 = easy to 5 = unable). Adverse experiences (fullness, cramps, nausea, vomiting, abdominal pain, headache and insomnia), number of evacuations and types of activities performed during preparation (walking or resting in bed) were also investigated. RESULTS: Seventy-two patients were selected for each group. The two groups were age and sex matched as well as being comparable in terms of medical history and drug therapies taken. Fourteen patients dropped out from the trial because they did not complete the preparation procedure. Ratings of global bowel cleansing examinations were considered to be adequate in 91% of PEG + Asc and 88% of PEG + Sim patients. Residual Stool Score indicated similar levels of amount and consistency of residual stool; there was a significant difference in the percentage of bowel wall visualization in favour of PEG + Sim patients. In the PEG + Sim group, 12 adenomas ≤ 10 mm diameter (5/left colon + 7/right colon) vs 9 (8/left colon + 1/right colon) in the PEG + Asc group were diagnosed. Visualization of small lesions seems to be one of the primary advantages of the PEG + Sim preparation. CONCLUSION: PEG + Asc is a good alternative solution as a bowel preparation but more improvements are necessary in order to achieve the target of a perfect preparation.


Assuntos
Ácido Ascórbico/uso terapêutico , Catárticos/uso terapêutico , Colonoscopia/métodos , Simeticone/uso terapêutico , Irrigação Terapêutica/métodos , Adulto , Idoso , Antioxidantes/uso terapêutico , Neoplasias Colorretais/diagnóstico , Emolientes/uso terapêutico , Humanos , Masculino , Pessoa de Meia-Idade , Soluções Farmacêuticas/química , Soluções Farmacêuticas/uso terapêutico , Polietilenoglicóis/uso terapêutico , Inquéritos e Questionários , Adulto Jovem
12.
Dig Liver Dis ; 42(8): 541-3, 2010 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-20061196

RESUMO

BACKGROUND: Current Italian guidelines suggest sequential therapy as first-line therapy and a levofloxacin-based rescue therapy for Helicobacter pylori eradication. We evaluated the efficacy of these therapies in clinical practice. METHODS: 84 consecutive patients with dyspeptic symptoms and proven H. pylori infection by either UBT or upper endoscopy with biopsies were enrolled. Patients received a 10-day sequential therapy with lansoprazole 30mg plus amoxycillin 1g (all twice daily) for the first 5 days, followed by lansoprazole 30mg, clarithromycin 500mg, and metronidazole 500mg (all twice daily) for the remaining 5 days. Eradication failure patients received triple therapy with lansoprazole 30mg, levofloxacin 250mg, and amoxycillin 1g (all twice daily) for 10 days. RESULTS: Following the sequential therapy H. pylori eradication was achieved in 70/84 (83.3%; 95% CI=75.4-91.3) patients, and in 70/77 (90.9%; 95% CI=84.5-97.3) patients at ITT and PP analyses, respectively. The infection was cured in all 7 eradication failure patients by using second-line therapy. CONCLUSIONS: A sequential regimen as first-line therapy and a 10-day levofloxacin-based triple regimen in those patients who failed to clear the infection, appear to be a valid therapeutic strategy for management of H. pylori infection in clinical practice.


Assuntos
Antibacterianos , Antiulcerosos , Gastroenteropatias/tratamento farmacológico , Infecções por Helicobacter/tratamento farmacológico , Helicobacter pylori/efeitos dos fármacos , 2-Piridinilmetilsulfinilbenzimidazóis/administração & dosagem , 2-Piridinilmetilsulfinilbenzimidazóis/efeitos adversos , 2-Piridinilmetilsulfinilbenzimidazóis/uso terapêutico , Adulto , Idoso , Idoso de 80 Anos ou mais , Amoxicilina/administração & dosagem , Amoxicilina/efeitos adversos , Amoxicilina/uso terapêutico , Antibacterianos/administração & dosagem , Antibacterianos/efeitos adversos , Antibacterianos/uso terapêutico , Antiulcerosos/administração & dosagem , Antiulcerosos/efeitos adversos , Antiulcerosos/uso terapêutico , Claritromicina/administração & dosagem , Claritromicina/efeitos adversos , Claritromicina/uso terapêutico , Esquema de Medicação , Quimioterapia Combinada , Feminino , Gastroenteropatias/etiologia , Gastroenteropatias/patologia , Infecções por Helicobacter/complicações , Infecções por Helicobacter/diagnóstico , Infecções por Helicobacter/patologia , Humanos , Itália , Lansoprazol , Levofloxacino , Masculino , Metronidazol/administração & dosagem , Metronidazol/efeitos adversos , Metronidazol/uso terapêutico , Pessoa de Meia-Idade , Ofloxacino/administração & dosagem , Ofloxacino/efeitos adversos , Ofloxacino/uso terapêutico , Resultado do Tratamento
14.
ABCD (São Paulo, Impr.) ; 12(3/4): 39-40, Jul.-Dec. 1997.
Artigo em Inglês | LILACS | ID: lil-225826

RESUMO

O Helicobacter pylori tem sido considerado importante fator nas doencas gastroduodenais e o esquema chamado triplice e o que mais se aceita no momento para a sua terapeutica. Neste estudo incluiram-se 14 pacientes portadores de gastrite cronica, 30 com ulcera gastrica e 16 com ulcera duodenal. Foram divididos em 2 grupos homogeneos para tratamento clinico, cada um com esquema bem definido: grupo A - claritromicina 250mg/2, tinidazol 250mg/2 e omeprazole 20mg em caso de gastrite e 40mg em caso de ulcera; grupo B - mesmos antibioticos e ranitidina respectivamente nas doses de 150 e 300mg. O periodo de tratamento foi de 7 dias para gastrites e 4 semanas para ulceras. Atraves de endoscopia e biopsia realizadas 30 dias depois do termino do tratamento, os 30 casos do grupo A tiveram erradicacao completa do Helicobacter pylori e cicatrizacao das ulceras. No grupo B, apenas 3 casos nao tiveram eliminacao do Helicobacter pylori. Concluiu-se que o uso de bloqueadores H2 no lugar de inibidores da bomba protonica tambem permite a obtencao de sucesso terapeutico


Assuntos
Humanos , Tinidazol/administração & dosagem , Tinidazol/antagonistas & inibidores , Tinidazol/uso terapêutico , Helicobacter pylori/efeitos dos fármacos , Claritromicina/administração & dosagem , Claritromicina/antagonistas & inibidores , Claritromicina/uso terapêutico , Antiulcerosos/uso terapêutico , Úlcera Duodenal/terapia , Úlcera Gástrica/terapia , Ranitidina/administração & dosagem , Ranitidina/uso terapêutico , Omeprazol/administração & dosagem , Omeprazol/uso terapêutico , Seguimentos , Endoscopia do Sistema Digestório , Bombas de Próton/uso terapêutico , Dispepsia/terapia , Gastrite/terapia , Antagonistas dos Receptores H2 da Histamina/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa